Apollo Hospitals Enterprise Limited

BSE:508869 Stock Report

Market Cap: ₹1.0t

Apollo Hospitals Enterprise Valuation

Is 508869 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 508869 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 508869 (₹7262.3) is trading above our estimate of fair value (₹3500.15)

Significantly Below Fair Value: 508869 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 508869?

Key metric: As 508869 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 508869. This is calculated by dividing 508869's market cap by their current earnings.
What is 508869's PE Ratio?
PE Ratio87.9x
Earnings₹11.88b
Market Cap₹1.04t

Price to Earnings Ratio vs Peers

How does 508869's PE Ratio compare to its peers?

The above table shows the PE ratio for 508869 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average72.2x
543220 Max Healthcare Institute
106.1x30.8%₹1.1t
FORTIS Fortis Healthcare
77.4x26.8%₹515.5b
NH Narayana Hrudayalaya
34.2x13.8%₹264.9b
KIMS Krishna Institute of Medical Sciences
71.1x24.9%₹239.6b
508869 Apollo Hospitals Enterprise
87.9x30.7%₹1.0t

Price-To-Earnings vs Peers: 508869 is expensive based on its Price-To-Earnings Ratio (87.9x) compared to the peer average (72.2x).

Price to Earnings Ratio vs Industry

How does 508869's PE Ratio compare vs other companies in the IN Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.4xn/aUS$13.31m
542918 Gian Life Care
5xn/aUS$2.26m
No more companies available in this PE range
508869 87.9xIndustry Avg. 42.4xNo. of Companies7PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 508869 is expensive based on its Price-To-Earnings Ratio (87.9x) compared to the Indian Healthcare industry average (42.4x).

Price to Earnings Ratio vs Fair Ratio

What is 508869's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

508869 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio87.9x
Fair PE Ratio80.8x

Price-To-Earnings vs Fair Ratio: 508869 is expensive based on its Price-To-Earnings Ratio (87.9x) compared to the estimated Fair Price-To-Earnings Ratio (80.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 508869 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹7,262.30
₹7,899.69
+8.8%
8.2%₹8,702.00₹5,700.00n/a29
Dec ’25₹6,829.80
₹7,899.69
+15.7%
8.2%₹8,702.00₹5,700.00n/a29
Nov ’25₹7,036.65
₹7,292.90
+3.6%
9.0%₹8,605.00₹5,040.00n/a29
Oct ’25₹7,155.20
₹7,239.93
+1.2%
8.1%₹7,949.00₹5,040.00n/a29
Sep ’25₹6,928.80
₹7,140.71
+3.1%
7.6%₹7,940.00₹5,040.00n/a28
Aug ’25₹6,702.35
₹6,867.39
+2.5%
7.3%₹7,670.00₹5,040.00n/a28
Jul ’25₹6,137.05
₹6,845.79
+11.5%
7.2%₹7,670.00₹5,040.00n/a28
Jun ’25₹5,839.95
₹6,827.59
+16.9%
10.2%₹7,670.00₹4,200.00n/a27
May ’25₹5,946.20
₹6,846.88
+15.1%
10.7%₹7,670.00₹4,200.00n/a26
Apr ’25₹6,453.40
₹6,970.88
+8.0%
10.7%₹7,850.00₹4,200.00n/a26
Mar ’25₹6,082.75
₹6,970.88
+14.6%
10.7%₹7,850.00₹4,200.00n/a26
Feb ’25₹6,287.45
₹6,119.62
-2.7%
9.3%₹7,000.00₹4,200.00n/a26
Jan ’25₹5,748.00
₹5,881.73
+2.3%
7.3%₹6,291.00₹4,200.00n/a26
Dec ’24₹5,586.30
₹5,877.88
+5.2%
7.3%₹6,291.00₹4,200.00₹6,829.8026
Nov ’24₹4,794.90
₹5,564.79
+16.1%
8.1%₹6,260.00₹4,200.00₹7,036.6524
Oct ’24₹5,137.40
₹5,543.54
+7.9%
7.8%₹6,260.00₹4,200.00₹7,155.2024
Sep ’24₹4,837.65
₹5,518.80
+14.1%
7.6%₹6,260.00₹4,200.00₹6,928.8025
Aug ’24₹5,030.60
₹5,383.50
+7.0%
7.9%₹6,260.00₹4,200.00₹6,702.3522
Jul ’24₹5,095.60
₹5,376.71
+5.5%
5.0%₹5,950.00₹4,730.00₹6,137.0521
Jun ’24₹4,818.60
₹5,328.24
+10.6%
4.0%₹5,698.00₹4,730.00₹5,839.9521
May ’24₹4,519.95
₹5,223.43
+15.6%
4.6%₹5,600.00₹4,690.00₹5,946.2021
Apr ’24₹4,309.40
₹5,249.81
+21.8%
4.1%₹5,700.00₹4,730.00₹6,453.4021
Mar ’24₹4,415.80
₹5,251.35
+18.9%
4.1%₹5,700.00₹4,730.00₹6,082.7520
Feb ’24₹4,268.10
₹5,227.15
+22.5%
4.1%₹5,600.00₹4,730.00₹6,287.4520
Jan ’24₹4,478.65
₹5,225.35
+16.7%
4.1%₹5,600.00₹4,730.00₹5,748.0020
Dec ’23₹4,774.10
₹5,225.35
+9.5%
4.1%₹5,600.00₹4,730.00₹5,586.3020

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 11:50
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Apollo Hospitals Enterprise Limited is covered by 55 analysts. 29 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Prashant NairAmbit Capital
Nitin BhasinAmbit Capital
null nullAnand Rathi Shares and Stock Brokers Limited